| P2093 | author name string | Jorge Luna-Abanto | |
| | Luis García Ruiz | |
| | Jheff Laura Martinez | |
| | Manuel Álvarez Larraondo | |
| | Vladimir Villoslada Terrones | |
| P2860 | cites work | How Effective Are Percutaneous Liver-Directed Therapies in Patients with Non-Colorectal Liver Metastases? | Q26764993 |
| | Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q34008331 |
| | Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients | Q35475560 |
| | Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer. | Q35867496 |
| | Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit | Q35914739 |
| | Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer | Q36814403 |
| | The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. | Q38242365 |
| | Percutaneous cryoablation of ovarian cancer metastasis to the liver: initial experience in 13 patients | Q38385170 |
| | Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients | Q38914961 |
| | Role of surgical resection for non-colorectal non-neuroendocrine liver metastases | Q39162735 |
| | Hepatic resection of non-colorectal non-endocrine liver metastases | Q39870005 |
| | Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary Sites | Q39951469 |
| | Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience. | Q41310221 |
| | Hepatectomy for liver metastases in non-colorectal, non-neuroendocrine cancer patients. The survival benefit in primary unresectable cases | Q41479365 |
| | The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. | Q44276725 |
| | Hepatic resection for metachronous metastases from ovarian carcinoma | Q44359509 |
| | Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. | Q44621833 |
| | Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study. | Q50072299 |
| | Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases. | Q52886422 |
| | The Clavien-Dindo classification of surgical complications: five-year experience. | Q53059133 |
| | Clinical features of hepatic metastasis in patients with ovarian cancer | Q57903507 |
| | Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery | Q63254285 |
| | Cytoreduction of diaphragmatic metastasis from ovarian cancer with involvement of the liver using a ventral liver mobilization technique | Q87143485 |
| | A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer | Q89022888 |
| | [Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the Peruvian National Institute of Neoplastic Diseases] | Q89165643 |
| | Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients | Q90004151 |
| P433 | issue | 2 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 70-75 | |
| P577 | publication date | 2020-03-31 | |
| P1433 | published in | Journal of gynecologic surgery | Q27709869 |
| P1476 | title | Liver Resection as Part of Cytoreductive Surgery for Ovarian Cancer | |
| P478 | volume | 36 | |